Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of the study is to determine whether the addition of Elotuzumab to Bortezomib/ Dexamethasone will prolong the time before myeloma worsens \[progression free survival (PFS)\].
Epistemonikos ID: bd492f0373d5fe00dd31e016b7789df299be3044
First added on: Jul 25, 2023